Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ 2,546,916	$ 2,363,509	$ 8,562,680	$ 6,843,024
Adjustments to reconcile net income to net cash provided by operating activities:
Additions to content assets	(4,653,935)	(4,016,396)	(12,039,405)	(11,794,215)
Change in content liabilities	24,262	(83,585)	(601,043)	(639,598)
Amortization of content assets	4,002,744	3,699,521	11,657,930	11,140,016
Depreciation and amortization of property, equipment and intangibles	87,326	80,914	247,406	249,375
Stock-based compensation expense	80,986	65,650	233,825	210,761
Foreign currency remeasurement loss (gain) on debt	(1,707)	104,809	82,078	(68,684)
Other non-cash items	142,293	128,082	377,162	363,851
Deferred income taxes	20,539	(200,982)	(279,144)	(517,446)
Changes in operating assets and liabilities:
Other current assets	(169,597)	54,956	(477,647)	64,046
Accounts payable	139,451	30,597	(125,929)	(134,026)
Accrued expenses and other liabilities	707,151	179,011	746,329	316,490
Deferred revenue	(3,686)	39,328	203,862	70,079
Other non-current assets and liabilities	(97,569)	(124,313)	(550,473)	(279,203)
Net cash provided by operating activities	2,825,174	2,321,101	8,037,631	5,824,470
Cash flows from investing activities:
Purchases of property and equipment	(164,719)	(126,863)	(448,885)	(280,864)
Purchases of investments	(3,850)	(1,742,246)	(161,515)	(1,742,246)
Proceeds from maturities and sales of investments	176,250	0	1,908,617	0
Other investing activities	36,190	0	0	0
Net cash provided by (used in) investing activities	43,871	(1,869,109)	1,298,217	(2,023,110)
Cash flows from financing activities:
Proceeds from issuance of debt	0	1,794,460	0	1,794,460
Repayments of debt	0	0	(1,833,450)	(400,000)
Proceeds from issuance of common stock	70,215	143,244	590,883	530,875
Repurchases of common stock	(1,856,885)	(1,700,000)	(7,047,608)	(5,299,998)
Taxes paid related to net share settlement of equity awards	(6,196)	(2,024)	(40,180)	(5,732)
Other financing activities	55,837	(9,084)	62,142	(15,334)
Net cash provided by (used in) financing activities	(1,737,029)	226,596	(8,268,213)	(3,395,729)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(21,721)	153,452	415,896	(65,061)
Net increase in cash, cash equivalents and restricted cash	1,110,295	832,040	1,483,531	340,570
Cash, cash equivalents and restricted cash at beginning of period	8,180,573	6,627,045	7,807,337	7,118,515
Cash, cash equivalents and restricted cash at end of period	$ 9,290,868	$ 7,459,085	$ 9,290,868	$ 7,459,085